4. 1.1.terminology
Bone remodeling is bone regeneration
process.
Osteoclast a bone eating cell in bone
resorption process.
Osteoblast a bone forming cell in bone
forming process.
RANKL Receptor activator of nuclear
factor kappa-Β ligand.
PTH(parathyroid horomone)
5. 1.2.Bone remodeling
Bone tissue regenerate
throughout the life in the
process colled’bone
remodeling’
It is of two form;
Bone resorption
Bone formation
In bone resorption
,osteoclast a bone eating
cell broke down bone.
In bone formation
,osteoblast a bone
forming cell form a bone.
6. 1.3.Bone remodeling
In paget disease there is
abnormality in bone
remodeling process
Osteoclast break down bone
first.
Osteoblast then build up bone
rapidly forming abnormally large
and deformed bone.
Etiology is unknown; possibly
viral
Localized process involving
one or more bones; does not
involve the entire skeleton
Usually seen in late adulthood
(average age > 60 years)
7. 1.4.Phase in paget disease
There are three phase in
paget disease
Osteolytic(lytic) phase.
Mixed phase.
Osteoblastic(scleolitic)
phase.
9. 1.6.Clinical features
Early on; typically no
symptom.
Over time, the deformed
bone.
Impinging on nerve couse
pain.
Impingination on CN VIII
lead to hearing loss.
Vision loss if CN II is
impinginated.
Lion-like facies’leontiasis’
High-output cardiac failure - due to
formation of AV shunts in bone
10.
11.
12. 1.7.Pharma&non-
pharmacologicol treatment.
Drug
Pain reliever.
Bisphosphonates:
Alendronate.
Risedronate.
Rankl inhibitor
Donesumab.
The use of VIT D have not yet
approved.
Teriparatide(PTH) has box
warning of osteosarcoma hence
not used.
Surgery is also essential to
Decompress the impanginated
nerve.
Collect bone deformity.
Reduce associated fracture.